Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Supraventricular tachycardia, Swelling face, Ventricular extrasystoles
Clinical narrative: chest pain; signs of super ventricular tachycardia; swelling on the right side of my face; Frequent palpitations; From the knees down, both legs felt numb into her feet; Could not stand; shortness of breath; Premature ventricular contractions; A spontaneous report was received from a consumer concerning a 55-years-old female patient , who received  Moderna's COVID-19 vaccine(mRNA-1273)  and experienced the following: chest pain, could not stand (dysstasia), shortness of breath (dyspnea), signs of supraventricular tachycardia (supraventricular tachycardia), swelling on the right side of face (swelling face), from the knees down, both legs felt numb into the feet (hypoaesthesia) , frequent palpitations (palpitations), premature ventricular contractions, a lot of them (ventricular extrasystole).  The patient's medical history was not provided. Relevant concomitant medications as reported included metoprolol .  On 29 Jan 2021, prior to the onset of events, the patient received their second of two planned doses  of  mRNA-1273(Lot/batch:013L20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On an unspecified date the patient experienced events swelling on the right side of face , signs of supraventricular tachycardia , frequent palpitations . On 01 Feb 2021, the patient experienced shortness of breath and a lot of premature ventricular contractions (this was confirmed by patient's doctor on an EKG).  On 05 Feb 2021, the patient reported they were starting to get in trouble. They woke up on 06 Feb 2021 with chest pain and very short of breath. From the knees down, both legs felt numb into the feet. By the end of the day, the patient could not stand. The patient's cardiologist prescribed metoprolol which was helping some. On an unknown date, the patient ended up in the emergency room (ER) with chest pain.  An echocardiogram didn't show much. The last week of February 2021 (dates unspecified) the patient reported they went to the ER again for chest pain. At that time, the numbness and tingling had gone away. The patient was admitted for two nights to the local hospital and while there had a poor exercise test and signs of superventricular tachycardia. Treatment included an increase in metoprolol, but the patient still had frequent palpitations. Metoprolol was again increased to control and monitor the heart. The patient is wearing a heart monitor.    The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  At the time of the report, the outcome of the events ,swelling on the right side of face,signs of supraventricular tachycardia , frequent palpitations, shortness of breath, premature ventricular contractions, chest pain, and could not stand, was unknown .  At the time of the report, the outcome of the event from the knees down both legs felt numb into the feet, was considered resolved .; Reporter's Comments: The events were consistent with increased risk of cardiovascular complications associated with age of patient. Company assessed the events to be unlikely related to company product.